Senior Manager/ Associate Director Patient Marketing and Sales Training

NanoString® Technologies, Inc.
Job Location
Seattle, WA 98109
Competitive Comp

Benefits include but are not limited to: Medical, Dental, Vision, Stock Options, ESPP, Matching 401K, transportation assistance, wellness reimbursement, PTO, and more...

Job Description

Job Summary:

The Patient Marketing and Sales Training is a combined role which will be responsible for planning, development, and execution of the Diagnostic Franchise Patient Marketing Plan and the management of our Sales Training Program.  The successful candidate will operate in close alignment with the franchise leadership team working directly with functional heads for Solid Tumor and Hematologic Marketing to develop effective communication tools targeting key patient segments.  The Patient Marketer will lead all the development of patient promotional campaigns and collateral. 

Sales Training responsibilities include establishing a comprehensive training curriculum which spans Diagnostic New Hire on-boarding through advanced selling skills seminars.  The successful candidate will leverage all forms of training media and will oversee our sales training portal.

Responsibilities and scope includes:

  • Lead the development and execution of Patient Marketing campaigns and promotional collateral
  • Develop patient centric innovative programs which compliment field promotional efforts
  • Develop patient product advocates and lead advocate management
  • Manage  market research initiatives in collaboration with Brand Leads to uncover market opportunities
  • Define segment specific training strategies which increase Diagnostic field effectiveness with each customer segment
  • Partner across Diagnostic Franchise Leadership to proactively address the needs of the field team elevating promotional skills while decreasing the time from new hire to field effectiveness. 
  • Maintain the existing training program to meets the individual needs of Diagnostic field team members while tracking their progress and growth through the training process
  • Partner with sales, medical affairs, global marketing, market access, legal, and regulatory to ensure aligned objectives and implementation of brand strategies
  • Proven team player with ability to frequently and successfully collaborate cross-functionally
  • Excellent written/verbal communication at all times. Experienced in delivering complex messages to various internal and external customers with a track record of effective and influential presentations.


  • 4-6 years Hematology/Oncology experience is required
  • 2-4 years of marketing and/or sales training experience is preferred
  • Prior clinical sales experience is required prior breast cancer experience is preferred
  • Project management skills
  • Exceptional presentation skills, both oral and written
  • Must be able to travel internationally
  • Identify, analyze and resolve problems in a timely manner
  • Work in a fast-paced, changing environment
How to Apply
About Our Organization

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable.

Leading researchers and institutions are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

In addition to continuing to extend the applications for the nCounter system in the discovery, target validation and routine testing segments of the genomics research market, the company's goal is to become the platform of choice for diagnostic testing based on multiplexed gene signatures that can be offered in hospitals and pathology laboratories worldwide, following appropriate regulatory approvals. These two synergistic areas of business focus provide researchers with a seamless transition from discovery to diagnostics.


At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.

A new survey from the Pew Research Center finds that half of women working in STEM have experienced gender discrimination at work.